WallStreetZenWallStreetZen

NASDAQ: BLFS
Biolife Solutions Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BLFS

Based on 1 analyst offering 12 month price targets for Biolife Solutions Inc

Min Forecast
$32.00+24.76%
Avg Forecast
$32.00+24.76%
Max Forecast
$32.00+24.76%

Should I buy or sell BLFS stock?

Based on 1 analyst offering ratings for Biolife Solutions Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BLFS's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates BLFS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their BLFS stock forecasts and price targets.

BLFS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-08

1 of 1

Forecast return on equity

Is BLFS forecast to generate an efficient return?

Company
N/A
Industry
17.59%
Market
-18.68%

Forecast return on assets

Is BLFS forecast to generate an efficient return on assets?

Company
N/A
Industry
12.56%

BLFS earnings per share forecast

What is BLFS's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$0.05
Avg 2 year Forecast
$0.12

BLFS revenue forecast

What is BLFS's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$100.7M+26.77%
Avg 2 year Forecast
$117.0M+47.38%
BLFS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BLFS revenue growth forecast

How is BLFS forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
21.4%
Industry
7.66%
Market
11.92%
BLFS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BLFS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BLFS vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
BLFS$25.65$32.00+24.76%Buy
PLSE$16.91$22.00+30.10%Buy
STAA$27.47$23.80-13.36%Hold
AZTA$30.57$36.00+17.76%Buy
KMTS$18.54$26.80+44.59%Strong Buy
View Top Medical Stocks

Biolife Solutions Stock Forecast FAQ

Is Biolife Solutions Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BLFS) stock is to Buy BLFS stock.

Out of 1 analyst, 0 (0%) are recommending BLFS as a Strong Buy, 1 (100%) are recommending BLFS as a Buy, 0 (0%) are recommending BLFS as a Hold, 0 (0%) are recommending BLFS as a Sell, and 0 (0%) are recommending BLFS as a Strong Sell.

If you're new to stock investing, here's how to buy Biolife Solutions stock.

What is BLFS's earnings growth forecast for 2025-2026?

(NASDAQ: BLFS) Biolife Solutions's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 19.08%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.77%.

Biolife Solutions's earnings in 2025 is -$10,411,000.On average, 1 Wall Street analyst forecast BLFS's earnings for 2025 to be $2,378,059, with the lowest BLFS earnings forecast at $2,378,059, and the highest BLFS earnings forecast at $2,378,059.

In 2026, BLFS is forecast to generate $5,864,292 in earnings, with the lowest earnings forecast at $3,804,894 and the highest earnings forecast at $9,036,622.

What is BLFS's revenue growth forecast for 2025-2026?

(NASDAQ: BLFS) Biolife Solutions's forecast annual revenue growth rate of 21.4% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.66%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.92%.

Biolife Solutions's revenue in 2025 is $79,416,000.On average, 4 Wall Street analysts forecast BLFS's revenue for 2025 to be $4,788,363,574, with the lowest BLFS revenue forecast at $4,656,238,641, and the highest BLFS revenue forecast at $4,851,239,442.

In 2026, BLFS is forecast to generate $5,566,559,454 in revenue, with the lowest revenue forecast at $5,431,485,728 and the highest revenue forecast at $5,686,413,605.

What is BLFS's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: BLFS) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 12.56%.

What is BLFS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BLFS price target, the average BLFS price target is $32.00, with the highest BLFS stock price forecast at $32.00 and the lowest BLFS stock price forecast at $32.00.

The Wall Street analyst predicted that Biolife Solutions's share price could reach $32.00 by Aug 8, 2026. The average Biolife Solutions stock price prediction forecasts a potential upside of 24.76% from the current BLFS share price of $25.65.

What is BLFS's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: BLFS) Biolife Solutions's current Earnings Per Share (EPS) is -$0.36. On average, analysts forecast that BLFS's EPS will be $0.05 for 2025, with the lowest EPS forecast at $0.05, and the highest EPS forecast at $0.05. In 2026, BLFS's EPS is forecast to hit $0.12 (min: $0.08, max: $0.19).

What is BLFS's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: BLFS) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.